LILLY 4165 (Evista 60 mg)

Generic Name: raloxifene

Pill imprint LILLY 4165 has been identified as Evista 60 mg.

Evista is used in the treatment of breast cancer, prevention; prevention of osteoporosis; osteoporosis and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. Not for use in pregnancy. Evista 60 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for LILLY 4165

Evista 60 mg LILLY 4165  Front
Evista 60 mg LILLY 4165  Back
Evista 60 mg LILLY 4165
Evista 60 mg LILLY 4165
Evista
Generic Name:
raloxifene
Imprint:
LILLY 4165
Strength:
60 mg
Color:
White
Size:
12.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Lilly, Eli and Company
National Drug Code (NDC):
00002-4165
Inactive Ingredients:
carnauba wax
crospovidone
hypromelloses
lactose monohydrate
lactose anhydrous
magnesium stearate
polyethylene glycol
povidone
titanium dioxide
polysorbate 80
propylene glycol
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-4628 A S Medication Solutions LLC (repackager)
54868-4170 Physicians Total Care Inc (repackager)
57866-0002 Direct Dispensing Inc (repackager)
55289-0266 PDRX Pharmaceuticals Inc (repackager)
49999-0458 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)